T. Rowe Price Investment Management’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $222M | Buy |
7,067,659
+15,841
| +0.2% | +$497K | 0.14% | 168 |
|
|
2025
Q1 | $209M | Buy |
7,051,818
+351,610
| +5% | +$10.4M | 0.14% | 166 |
|
|
2024
Q4 | $198M | Buy |
6,700,208
+200,373
| +3% | +$5.91M | 0.12% | 180 |
|
|
2024
Q3 | $202M | Buy |
6,499,835
+3,507,562
| +117% | +$109M | 0.12% | 183 |
|
|
2024
Q2 | $101M | Buy |
2,992,273
+2,258,662
| +308% | +$76.5M | 0.06% | 279 |
|
|
2024
Q1 | $47.7M | Buy |
733,611
+359,050
| +96% | +$23.3M | 0.03% | 403 |
|
|
2023
Q4 | $25.6M | Buy |
+374,561
| New | +$25.6M | 0.02% | 467 |
|